Should we screen for asymptomatic left ventricular dysfunction to prevent heart failure?

被引：64

作者：

McMurray, JV

McDonagh, TA

Davie, AP

Cleland, JGF

Francis, CM

Morrison, C

机构：

[1] Univ Glasgow, MRC CRI Heart Failure, Glasgow G12 8QQ, Lanark, Scotland

[2] Univ Glasgow, Dept Publ Hlth, Glasgow G12 8QQ, Lanark, Scotland

[3] Victoria Hosp, Dept Med Cardiol, Kirkcaldy, Fife, Scotland

来源：

EUROPEAN HEART JOURNAL | 1998年 / 19卷 / 06期

基金：

英国医学研究理事会;

关键词：

D O I：

10.1093/eurheartj/19.6.842

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A programme to detect and treat asymptomatic left ventricular dysfunction would seem to fulfil all five principles of screening. Indeed, such a programme would appear to be at least as firmly based as those already in existence for, for example, cervical and breast cancer. Further evaluation of the screening of high risk groups to detect asymptomatic left ventricular systolic dysfunction with the aim of giving treatment to prevent the development of heart failure is merited.

引用

页码：842 / 846

页数：5

共 52 条

[1]

Abernathy GT, 1996, CONTROL CLIN TRIALS, V17, P77

[2] THE EFFECT OF THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR ZOFENOPRIL ON MORTALITY AND MORBIDITY AFTER ANTERIOR MYOCARDIAL-INFARCTION [J].